Global Epigenetics Market Size More Than Doubles at Robust CAGR of 15.2%, to Reach USD 5.47 Billion by 2030
Global Epigenetics Market is flourishing because of and increasing focus on the treatment and management of rising prevalence of cancer and intensifying R&D activities in the healthcare sector, along with expanding scope of personalized medicine.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Epigenetics Market size at USD 2.34 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Epigenetics Market size to expand at a CAGR of 15.20% reaching a value of USD 5.47 billion by 2030. The growing prevalence of chronic illnesses, including cancer and cardiovascular diseases, as well as an increase in pharmaceutical research and development are significant driving factors for the Global Epigenetics Market. Moreover, throughout the projected period, the development of targeted medicines and a growing emphasis on customized medicine are expected to provide substantial opportunities for players in the Global Epigenetic Market.
Opportunity: Advanced research and development activities
With the rising prevalence of various chronic diseases, various pharmaceutical and biotechnology companies are increasing their investments in R&D programs to make advancements in epigenetics and expand its application in non-oncology segments as well. A recent study published in the scientific journal Nature explores the epigenetic changes in cancer progression as well as identifies the cellular pathways of these genes that may potentially prove crucial in developing strategies for maximizing the therapeutic benefits while minimizing the side effects. Positive outcomes from research and development activities are anticipated to provide lucrative growth opportunities for companies in the Global Epigenetics Market over the forecast period.
Impact of Escalating Geopolitical Tensions on Global Epigenetics Market
The escalating geopolitical tensions hampered the growth of the global epigenetics market. For instance, Ukraine is one of the leading healthcare providers and engages in extensive research and development activities. However, after Russia attacked Ukraine in February 2022, the healthcare and clinical infrastructure of Ukraine were impacted. Patients from abroad as well as those within Ukraine experienced difficulties accessing healthcare resources due to the regional unrest in the country, especially in the Kyiv region. Research collaborations and international partnerships in clinical research may be put under pressure after the situation in Ukraine, which might impede advancements in the sector. Essentially, these geopolitical tensions highlight the necessity for strategic adaptability and resilience in navigating these challenging conditions by introducing uncertainties and obstacles across all aspects of the epigenetics business.
Global Epigenetics Market
Segmental Coverage
Global Epigenetics Market – By Technology
Based on technology, the Global Epigenetics Market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, and Chromatin Structures. DNA methylation technology holds the largest share in the Global Epigenetics Market. According to a report published in The Lancet, with tissue-specific variations, methylation may be utilized in a basic cell-free circulating-DNA blood test to identify cell death and track several prevalent diseases. Additionally, it demonstrates the enormous potential for disease diagnosis, customized treatment, and prevention.
Global Epigenetics Market - By Region
The in-depth research report on the Global Epigenetics Market covers the market in a major number of countries across five regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Epigenetics Market. Accessible healthcare services, along with advanced medical infrastructure, act as a major driving factor for market growth in the region. Moreover, extensive research and development activities surrounding epigenetics, owing to the high concentration of leading pharmaceutical companies and favorable government support, contribute to the epigenetics market growth in North America.
Competitive Landscape
Major players operating in the Global Epigenetics Market include Qiagen, Thermo Fisher Scientific, Illumina, Agilent Technologies, Zymo Research, Clontech, New England Biolabs (NEB), EpigenTek Group Inc., Active Motif, and Diagenode. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Epigenetics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Epigenetics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Global Epigenetics Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising Prevalence of Chronic Diseases
- 3.2.1.2. Advances in Epigenetic Technologies
- 3.2.1.3. Increasing Investment in Epigenetics Research
- 3.2.2. Restraints
- 3.2.2.1. Data Privacy Concerns
- 3.2.2.2. Cost of Epigenetic Technologies
- 3.2.3. Opportunities
- 3.2.3.1. Development of Personalized Medicine
- 3.2.3.2. Expansion into New Applications
- 3.2.4. Challenges
- 3.2.4.1. Regulatory Hurdles
- 3.2.4.2. Lack of Standardization
- 3.3. Technological Advancements/Recent Developments
- 3.4. Consumer Behavior and Insights
- 3.5. Regulatory Framework
- 3.6. Porter’s Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of New Entrants
- 3.6.4. Threat of Substitutes
- 3.6.5. Intensity of Rivalry
- 4. Global Epigenetics Market Overview
- 4.1. Market Size & Forecast, 2019–2030
- 4.1.1. By Value (USD Billion)
- 4.2. Market Share and Forecast
- 4.2.1. By Product
- 4.2.1.1. Reagents
- 4.2.1.2. Kits
- 4.2.1.2.1. Chip Sequencing Kit
- 4.2.1.2.2. Whole Genomic Amplification Kit
- 4.2.1.2.3. Bisulfite Conversion Kit
- 4.2.1.2.4. RNA Sequencing Kit
- 4.2.1.2.5. Others
- 4.2.1.3. Instruments
- 4.2.1.4. Enzymes
- 4.2.1.5. Services
- 4.2.2. By Technology
- 4.2.2.1. DNA Methylation
- 4.2.2.2. Histone Methylation
- 4.2.2.3. Histone Acetylation
- 4.2.2.4. Large Non - Coding RNA
- 4.2.2.5. MicroRNA Modification
- 4.2.2.6. Chromatin Structures
- 4.2.3. By Application
- 4.2.3.1. Oncology
- 4.2.3.1.1. Solid Tumors
- 4.2.3.1.2. Liquid Tumors
- 4.2.3.2. Non - Oncology
- 4.2.3.2.1. Inflammatory Diseases
- 4.2.3.2.2. Metabolic Diseases
- 4.2.3.2.3. Infectious Diseases
- 4.2.3.2.4. Cardiovascular Diseases
- 4.2.3.2.5. Others
- 4.2.4. By Region
- 4.2.4.1. North America
- 4.2.4.2. Europe
- 4.2.4.3. Asia Pacific (APAC)
- 4.2.4.4. Latin America (LATAM)
- 4.2.4.5. Middle East and Africa (MEA)
- 5. North America Epigenetics Market
- 5.1. Market Size & Forecast, 2019–2030
- 5.1.1. By Value (USD Billion)
- 5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Technology
- 5.2.3. By Application
- 5.2.4. By Country
- 5.2.4.1. United States
- 5.2.4.1.1. By Product
- 5.2.4.1.2. By Technology
- 5.2.4.1.3. By Application
- 5.2.4.2. Canada
- 5.2.4.2.1. By Product
- 5.2.4.2.2. By Technology
- 5.2.4.2.3. By Application
- 6. Europe Epigenetics Market
- 6.1. Market Size & Forecast, 2019–2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Technology
- 6.2.3. By Application
- 6.2.4. By Country
- 6.2.4.1. Germany
- 6.2.4.1.1. By Product
- 6.2.4.1.2. By Technology
- 6.2.4.1.3. By Application
- 6.2.4.2. United Kingdom
- 6.2.4.2.1. By Product
- 6.2.4.2.2. By Technology
- 6.2.4.2.3. By Application
- 6.2.4.3. Italy
- 6.2.4.3.1. By Product
- 6.2.4.3.2. By Technology
- 6.2.4.3.3. By Application
- 6.2.4.4. France
- 6.2.4.4.1. By Product
- 6.2.4.4.2. By Technology
- 6.2.4.4.3. By Application
- 6.2.4.5. Spain
- 6.2.4.5.1. By Product
- 6.2.4.5.2. By Technology
- 6.2.4.5.3. By Application
- 6.2.4.6. Belgium
- 6.2.4.6.1. By Product
- 6.2.4.6.2. By Technology
- 6.2.4.6.3. By Application
- 6.2.4.7. Russia
- 6.2.4.7.1. By Product
- 6.2.4.7.2. By Technology
- 6.2.4.7.3. By Application
- 6.2.4.8. The Netherlands
- 6.2.4.8.1. By Product
- 6.2.4.8.2. By Technology
- 6.2.4.8.3. By Application
- 6.2.4.9. Rest of Europe
- 6.2.4.9.1. By Product
- 6.2.4.9.2. By Technology
- 6.2.4.9.3. By Application
- 7. Asia Pacific Epigenetics Market
- 7.1. Market Size & Forecast, 2019–2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Technology
- 7.2.3. By Application
- 7.2.4. By Country
- 7.2.4.1. China
- 7.2.4.1.1. By Product
- 7.2.4.1.2. By Technology
- 7.2.4.1.3. By Application
- 7.2.4.2. India
- 7.2.4.2.1. By Product
- 7.2.4.2.2. By Technology
- 7.2.4.2.3. By Application
- 7.2.4.3. Japan
- 7.2.4.3.1. By Product
- 7.2.4.3.2. By Technology
- 7.2.4.3.3. By Application
- 7.2.4.4. South Korea
- 7.2.4.4.1. By Product
- 7.2.4.4.2. By Technology
- 7.2.4.4.3. By Application
- 7.2.4.5. Australia & New Zealand
- 7.2.4.5.1. By Product
- 7.2.4.5.2. By Technology
- 7.2.4.5.3. By Application
- 7.2.4.6. Indonesia
- 7.2.4.6.1. By Product
- 7.2.4.6.2. By Technology
- 7.2.4.6.3. By Application
- 7.2.4.7. Malaysia
- 7.2.4.7.1. By Product
- 7.2.4.7.2. By Technology
- 7.2.4.7.3. By Application
- 7.2.4.8. Singapore
- 7.2.4.8.1. By Product
- 7.2.4.8.2. By Technology
- 7.2.4.8.3. By Application
- 7.2.4.9. Vietnam
- 7.2.4.9.1. By Product
- 7.2.4.9.2. By Technology
- 7.2.4.9.3. By Application
- 7.2.4.10. Rest of APAC
- 7.2.4.10.1. By Product
- 7.2.4.10.2. By Technology
- 7.2.4.10.3. By Application
- 8. Latin America Epigenetics Market
- 8.1. Market Size & Forecast, 2019–2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Technology
- 8.2.3. By Application
- 8.2.4. By Country
- 8.2.4.1. Brazil
- 8.2.4.1.1. By Product
- 8.2.4.1.2. By Technology
- 8.2.4.1.3. By Application
- 8.2.4.2. Mexico
- 8.2.4.2.1. By Product
- 8.2.4.2.2. By Technology
- 8.2.4.2.3. By Application
- 8.2.4.3. Argentina
- 8.2.4.3.1. By Product
- 8.2.4.3.2. By Technology
- 8.2.4.3.3. By Application
- 8.2.4.4. Peru
- 8.2.4.4.1. By Product
- 8.2.4.4.2. By Technology
- 8.2.4.4.3. By Application
- 8.2.4.5. Rest of LATAM
- 8.2.4.5.1. By Product
- 8.2.4.5.2. By Technology
- 8.2.4.5.3. By Application
- 9. Middle East & Africa Epigenetics Market
- 9.1. Market Size & Forecast, 2019–2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Technology
- 9.2.3. By Application
- 9.2.4. By Country
- 9.2.4.1. Saudi Arabia
- 9.2.4.1.1. By Product
- 9.2.4.1.2. By Technology
- 9.2.4.1.3. By Application
- 9.2.4.2. UAE
- 9.2.4.2.1. By Product
- 9.2.4.2.2. By Technology
- 9.2.4.2.3. By Application
- 9.2.4.3. Qatar
- 9.2.4.3.1. By Product
- 9.2.4.3.2. By Technology
- 9.2.4.3.3. By Application
- 9.2.4.4. Kuwait
- 9.2.4.4.1. By Product
- 9.2.4.4.2. By Technology
- 9.2.4.4.3. By Application
- 9.2.4.5. South Africa
- 9.2.4.5.1. By Product
- 9.2.4.5.2. By Technology
- 9.2.4.5.3. By Application
- 9.2.4.6. Nigeria
- 9.2.4.6.1. By Product
- 9.2.4.6.2. By Technology
- 9.2.4.6.3. By Application
- 9.2.4.7. Algeria
- 9.2.4.7.1. By Product
- 9.2.4.7.2. By Technology
- 9.2.4.7.3. By Application
- 9.2.4.8. Rest of MEA
- 9.2.4.8.1. By Product
- 9.2.4.8.2. By Technology
- 9.2.4.8.3. By Application
- 10. Competitive Landscape
- 10.1. List of Key Players and Their Offerings
- 10.2. Global Epigenetics Market Share Analysis, 2023
- 10.3. Competitive Benchmarking, By Operating Parameters
- 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- 11. Impact of Escalating Geopolitical Tensions on Global Epigenetics Market
- 12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 12.1. Qiagen
- 12.2. Thermo Fisher Scientific
- 12.3. Illumina
- 12.4. Agilent Technologies
- 12.5. Zymo Research
- 12.6. Clontech
- 12.7. New England Biolabs (NEB)
- 12.8. EpigenTek Group Inc.
- 12.9. Active Motif
- 12.10. Diagenode
- 12.11. Other Prominent Players
- 13. Key Strategic Recommendations
- 14. Research Methodology
- 14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
- 14.2. Quantitative Research
- 14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
- 14.4. Breakdown of Primary Research Respondents, By Region
- 14.5. Assumptions & Limitations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook